Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01847001
What this trial is testing

Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Who this might be right for
Locally Advanced Malignant NeoplasmBreast Cancer
Columbia University 10
Not applicableLooking for participantsNCT02918474
What this trial is testing

Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+20 more
M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT02883062
What this trial is testing

Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer

Who this might be right for
Invasive Breast CarcinomaStage II Breast Cancer AJCC v6 and v7Stage III Breast Cancer AJCC v7+1 more
National Cancer Institute (NCI) 67
Large-scale testing (Phase 3)Ended earlyNCT01568346
What this trial is testing

Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 9
Early research (Phase 1)Ended earlyNCT04060342
What this trial is testing

GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more
GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Not applicableStudy completedNCT00086762
What this trial is testing

Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors

Who this might be right for
Chemotherapy-induced Nausea and VomitingUnspecified Adult Solid Tumor, Protocol SpecificBreast Cancer+3 more
M.D. Anderson Cancer Center 474
Not applicableStudy completedNCT01320540
What this trial is testing

4R for Guideline Indicated BRCA Testing of Breast Center Patients

Who this might be right for
Newly Diagnosed Carcinoma of BreastGenetic Predisposition to Disease
Northwestern University 75
Large-scale testing (Phase 3)Study completedNCT02149524
What this trial is testing

Compare the Effect of SB3 and Herceptin® in Women With HER2 Positive Breast Cancer

Who this might be right for
HER2 Positive Early or Locally Advanced Breast Cancer
Samsung Bioepis Co., Ltd. 875
Not applicableUnknownNCT01152775
What this trial is testing

Evaluation of the Use of Multimedia to Enhance Patient and Family Understanding

Who this might be right for
The Role of Multimedia on Retention and Comprehension of Key Concepts for Surgical Options in Newly Diagnosed Breast Cancer Patients.
McGill University Health Centre/Research Institute of the McGill University Health Centre 60
Not applicableLooking for participantsNCT03177902
What this trial is testing

Evaluation of Thyroid Abnormity Incidence and Thyroid Toxicity During Chemotherapy Among Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer FemaleThyroid Gland
The First Affiliated Hospital of Bengbu Medical University 400
Not applicableStudy completedNCT00336102
What this trial is testing

Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers

Who this might be right for
Breast CancerFatigueHypothyroidism
University of South Florida 541
Not applicableUnknownNCT02340494
What this trial is testing

An Online Enhanced Education Tool for Young Women Newly Diagnosed With Breast Cancer

Who this might be right for
EducationBreast NeoplasmsInternet+1 more
Women's College Hospital 200
Not applicableStudy completedNCT05549687
What this trial is testing

E-Health Support Program (PACK Health Program) in Supporting Patient Reported Symptoms in Newly Diagnosed Patients With Breast Cancer

Who this might be right for
Breast Carcinoma
M.D. Anderson Cancer Center 419
Not applicableStudy completedNCT04354675
What this trial is testing

Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 35
Not applicableStudy completedNCT01928186
What this trial is testing

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

Who this might be right for
Estrogen Receptor PositiveHER2/Neu NegativeMale Breast Carcinoma+7 more
University of Washington 28
Large-scale testing (Phase 3)Not Yet RecruitingNCT07269691
What this trial is testing

RaSOLVE: 125I Radioactive Seed Marking Effects on Pathological Complete Response Rate and Prognosis Post-Neoadjuvant Therapy in Early/Advanced Breast Cancer

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)Breast Cancer
Pengfei Qiu 194
Testing effectiveness (Phase 2)Ended earlyNCT00080626
What this trial is testing

Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Study completedNCT00410657
What this trial is testing

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)Study completedNCT01816594
What this trial is testing

NeoPHOEBE: Neoadjuvant Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive Primary Breast Cancer

Who this might be right for
HER2-positive Newly Diagnosed, Primary Breast Cancer
Novartis Pharmaceuticals 50
Testing effectiveness (Phase 2)Study completedNCT00093002
What this trial is testing

Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 179
Next Page